Decreased angiotensin II response but unaltered cardiovascular pressor response to infused norepinephrine after sodium restriction and converting enzyme inhibition.
Decreased angiotensin II response but unaltered cardiovascular pressor response to infused norepinephrine after sodium restriction and converting enzyme inhibition.
复制标题
限制钠摄入和抑制转化酶后,血管紧张素 II 反应降低,但对输注去甲肾上腺素的心血管升压反应未改变。
DOI:
10.1038/clpt.1993.50
复制
发表时间:
1993
影响因子:
6.7
通讯作者:
Brown,MR
中科院分区:
文献类型:
--
作者:
Mills,PJ;Dimsdale,JE;Ziegler,MG;Nelesen,RA;Brown,MR
Although studies indicate that converting enzyme inhibitors such as captopril influence α‐adrenergic physiology, the data on α‐adrenergic physiology is inconsistent. This study therefore examined the effects of captopril (50 mg/day for 5 days) during sodium restriction on the pressor response and on angiotensin II and neuropeptide Y levels to infused norepinephrine (0.01 to 0.1 μg/kg/min) in 17 hypertensive and 27 normotensive subjects. Angiotensin II increased significantly in response to infused norepinephrine during placebo administration(p< 0.001) but not during captopril administration(p= 0.15). Neuropeptide Y levels decreased in response to captopril(p= 0.02). Despite these changes the pressor response to infused norepinephrine was unchanged with captopril. These data support the conclusion that the antihypertensive action of captopril is unrelated to alterations in norepinephrine‐mediated α‐adrenergic pressor regulation. The finding of a decrease in neuropeptide Y levels may have relevance to the therapeutic effects of captopril.Clinical Pharmacology and Therapeutics(1993)53,450–456; doi:10.1038/clpt.1993.50